Dana N Raugi1, Geoffrey S Gottlieb, Papa S Sow, Macoumba Toure, Fatima Sall, Awa Gaye, Ibra N'doye, Nancy B Kiviat, Stephen E Hawes. 1. aDepartment of Epidemiology, School of Public Health bDepartment of Medicine, Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, Washington, USA cClinique des Maladies Infectieuses Ibrahima DIOP Mar dDepartment of Dentistry, Centre Hospitalier Universitaire de Fann, Universite Cheikh Anta Diop de Dakar, Dakar, Senegal eInstitut d'Hygiene Sociale, Dakar, Senegal fDepartment of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.
Abstract
OBJECTIVE: Dual infection with HIV-1 and HIV-2, which is not uncommon in West Africa, has implications for transmission, progression, and antiretroviral therapy (ART). Few studies have examined viral dynamics in this setting. Our objective was to directly compare HIV-1 and HIV-2 viral loads and to examine whether this relationship is associated with CD4⁺ cell count. STUDY DESIGN: This is a retrospective analysis of data from observational cohort studies. METHODS: We compared HIV-1 and HIV-2 viral loads from 65 dually infected, ART-naive Senegalese individuals. Participants provided blood, oral fluid, and cervicovaginal lavage (CVL) or semen samples for virologic and immunologic testing. We assessed relationships between HIV-1 and HIV-2 levels using linear regression with generalized estimating equations to account for multiple study visits. RESULTS: After adjusting for CD4⁺ cell count, age, sex, and commercial sex work, HIV-1 RNA levels were significantly higher than HIV-2 levels in semen, CVL, and oral fluids. Despite similar peripheral blood mononuclear cell DNA levels among individuals with CD4⁺ cell counts above 500 cells/μl, individuals with CD4⁺ cell counts below 500 cells/μl had higher HIV-1 and lower HIV-2 DNA levels. Individuals with high CD4⁺ cell counts had higher mean HIV-1 plasma RNA viral loads than HIV-2, with HIV-1 levels significantly higher and HIV-2 levels trending toward lower mean viral loads among individuals with low CD4⁺ cell counts. CONCLUSION: Our data are consistent with the hypothesis that with disease progression, HIV-1 outcompetes HIV-2 in dually infected individuals. This finding helps explain differences in prevalence and outcomes between HIV-1, HIV-2, and HIV-dual infection.
OBJECTIVE: Dual infection with HIV-1 and HIV-2, which is not uncommon in West Africa, has implications for transmission, progression, and antiretroviral therapy (ART). Few studies have examined viral dynamics in this setting. Our objective was to directly compare HIV-1 and HIV-2 viral loads and to examine whether this relationship is associated with CD4⁺ cell count. STUDY DESIGN: This is a retrospective analysis of data from observational cohort studies. METHODS: We compared HIV-1 and HIV-2 viral loads from 65 dually infected, ART-naive Senegalese individuals. Participants provided blood, oral fluid, and cervicovaginal lavage (CVL) or semen samples for virologic and immunologic testing. We assessed relationships between HIV-1 and HIV-2 levels using linear regression with generalized estimating equations to account for multiple study visits. RESULTS: After adjusting for CD4⁺ cell count, age, sex, and commercial sex work, HIV-1 RNA levels were significantly higher than HIV-2 levels in semen, CVL, and oral fluids. Despite similar peripheral blood mononuclear cell DNA levels among individuals with CD4⁺ cell counts above 500 cells/μl, individuals with CD4⁺ cell counts below 500 cells/μl had higher HIV-1 and lower HIV-2 DNA levels. Individuals with high CD4⁺ cell counts had higher mean HIV-1 plasma RNA viral loads than HIV-2, with HIV-1 levels significantly higher and HIV-2 levels trending toward lower mean viral loads among individuals with low CD4⁺ cell counts. CONCLUSION: Our data are consistent with the hypothesis that with disease progression, HIV-1 outcompetes HIV-2 in dually infected individuals. This finding helps explain differences in prevalence and outcomes between HIV-1, HIV-2, and HIV-dual infection.
Authors: Geoffrey S Gottlieb; Papa Salif Sow; Stephen E Hawes; Ibra Ndoye; Mary Redman; Awa M Coll-Seck; Mame A Faye-Niang; Aissatou Diop; Jane M Kuypers; Cathy W Critchlow; Richard Respess; James I Mullins; Nancy B Kiviat Journal: J Infect Dis Date: 2002-03-19 Impact factor: 5.226
Authors: J N Nkengasong; L Kestens; P D Ghys; S Koblavi-Dème; R A Otten; C Bilé; C Maurice; M Kalou; M Laga; S Z Wiktor; A E Greenberg Journal: AIDS Res Hum Retroviruses Date: 2000-09-20 Impact factor: 2.205
Authors: Stéphania Koblavi-Dème; Luc Kestens; Debra Hanson; Ronald A Otten; Marie-Yolande Borget; Célestin Bilé; Stefan Z Wiktor; Thierry H Roels; Terence Chorba; John N Nkengasong Journal: AIDS Date: 2004-02-20 Impact factor: 4.177
Authors: K Heitzinger; P S Sow; N M Dia Badiane; G S Gottlieb; I N'Doye; M Toure; N B Kiviat; S E Hawes Journal: Int J STD AIDS Date: 2012-10 Impact factor: 1.359
Authors: Abraham S Alabi; Shabbar Jaffar; Koya Ariyoshi; Tom Blanchard; Maarten Schim van der Loeff; Akum Aveika Awasana; Tumani Corrah; Sehu Sabally; Ramu Sarge-Njie; Fatim Cham-Jallow; Assan Jaye; Neil Berry; Hilton Whittle Journal: AIDS Date: 2003-07-04 Impact factor: 4.177
Authors: Geoffrey S Gottlieb; Papa Salif Sow; Stephen E Hawes; Ibra Ndoye; Awa M Coll-Seck; Marcel E Curlin; Cathy W Critchlow; Nancy B Kiviat; James I Mullins Journal: AIDS Res Hum Retroviruses Date: 2003-07 Impact factor: 2.205
Authors: Ming Chang; Katrin Steinmetzer; Dana N Raugi; Robert A Smith; Selly Ba; Fatima Sall; Moussa Seydi; Alassane Niang; ElHadji Ibrahima Sall; Ousseynou Cisse; Katja Rödel; Robert W Coombs; Geoffrey S Gottlieb Journal: J Clin Virol Date: 2017-10-24 Impact factor: 3.168
Authors: Robert A Smith; Dana N Raugi; Charlotte Pan; Papa Salif Sow; Moussa Seydi; James I Mullins; Geoffrey S Gottlieb Journal: Retrovirology Date: 2015-02-05 Impact factor: 4.602